2023 is an important milestone for Greenyn Biotechnology, as we officially went public in May. This report is our second sustainability report, representing our commitment to exceeding regulatory requirements in ESG development. Sustainable management remains our unwavering mission and reflects the corporate social responsibility we uphold. Green Field will continue to implement reforms and optimize various aspects of sustainability in a gradual and continuous manner.

2022 is an important year for Greenyn Biotechnology to move towards sustainable development. By compiling and issuing the first ESG report, implementing the identification of major themes, establishing the risk assessment of major themes, and establishing sustainable development goals, we are honored to present our The first ESG report, which is an important milestone in our future development path. Greenyn Biotechnoloyg will continue to work tirelessly to practice our reform and development journey, and work hand in hand with various stakeholders to achieve a more sustainable future.